Degarelix clinical trials: 63 trials
Page 2 of 2
- Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy
NCT01446991 · Phase 2 · Completed
Linked paper with results
- Degarelix Neo-Adjuvant Radical Prostatectomy Trial
NCT01674270 · Phase 2 · Completed
Linked paper with results
- Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC)
NCT01630967 · Phase 2 · Withdrawn
Linked paper with results
- Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer
NCT05617885 · Phase 1 · Terminated
Posted results
- Neoadjuvant ADT With TULSA in the Treatment of Intermediate Risk Prostate Cancer
NCT05917860 · Phase 1 · Active, not recruiting
Linked paper with results
- A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON
NCT01234350 · Phase not stated · Completed
Posted results
- FIRMAGON® Intensive Drug Monitoring
NCT05181800 · Phase not stated · Completed
Posted results
- Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
NCT05701007 · Phase not stated · Completed
Posted results
- Dysregulation of FSH in Obesity: Functional and Statistical Analysis
NCT02478775 · Not applicable · Completed
Posted results
- Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer
NCT01542021 · Not applicable · Completed
Posted results
- Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer
NCT01731912 · Not applicable · Completed
Posted results
- Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer
NCT02489357 · Not applicable · Completed
Posted results
- Treatment of Prostate Cancer With Firmagon®
NCT01710098 · Phase not stated · Completed
Linked paper with results